Loading...
ROCO
4139
Market cap33mUSD
Jul 09, Last price  
24.90TWD
1D
1.01%
1Q
-0.80%
Jan 2017
-10.56%
IPO
-14.40%
Name

Ma Kuang Healthcare Holding Ltd

Chart & Performance

D1W1MN
ROCO:4139 chart
P/E
P/S
0.97
EPS
Div Yield, %
Shrs. gr., 5y
0.31%
Rev. gr., 5y
3.72%
Revenues
1.09b
-3.34%
1,020,189,000910,240,000959,454,0001,058,745,0001,218,116,0001,130,262,0001,092,508,000
Net income
-67m
L
67,619,00077,164,00038,541,000-30,901,000-42,530,00010,282,000-67,081,999
CFO
239m
-29.76%
0294,677,000232,072,000189,875,000199,585,000340,128,000238,899,000
Dividend
Aug 26, 20211.6 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ma Kuang Healthcare Holding Limited, established in 2009 and headquartered in Kaohsiung, Taiwan, functions as an investment holding firm with a broad international and domestic presence in the healthcare sector. The company's core business involves a comprehensive range of medical services, including general community healthcare and specialized traditional Chinese medicine. Beyond direct patient care, Ma Kuang provides Chinese medicinal products, medical management training, and educational support. Its diverse offerings extend to homestay and guardianship services for overseas students, as well as a variety of consulting services encompassing corporate management, computer technology, industry information, and marketing advice. It also offers Chinese medicine beauty services and e-commerce sales. Ma Kuang manages and operates numerous facilities, such as general clinics, community medical clinics, and traditional Chinese medicine clinics, alongside educational institutions. The company further diversifies its activities through the retail sale of dietary supplements, pharmaceuticals, and medical supplies in its stores, involvement in the restaurant industry, and offering leasing and other ancillary services.
IPO date
Oct 28, 2009
Employees
Domiciled in
KY
Incorporated in
KY

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT